【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Biosimilars: Overview
• Comparative analysis of biosimilars and generic small molecules
• Biosimilars market opportunities
• Challenges for new entrants
• Bio-betters
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by application
• Global blood disorders biosimilars market
• Market overview
• Global oncology biosimilars market
• Global chronic and autoimmune diseases biosimilars market
• Global growth hormone deficiency biosimilars market
• Global infectious diseases biosimilars market
• Others
PART 08: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 09: Geographical segmentation
• Global biosimilars market by geographical segmentation 2015-2020
• Biosimilars market in EMEA
• Biosimilars market in APAC
• Biosimilars market in Americas
PART 10: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Reimbursement benefits for biosimilars
• Favorable government regulations
• Promising pipeline
PART 11: Impact of drivers
PART 12: Market challenges
• Physicians reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Risks related to drug failure
• Limited availability of biosimilar products
• Difficulties in patient recruitment for conducting clinical trials
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of biosimilars
• Outsourcing of biosimilar manufacturing activities
• Need for high investment in R&D
• High growth in the emerging markets
• Rising number of strategic collaborations
PART 15: Vendor landscape
• Competitive scenario
• Sandoz
• Hospira
• Teva Pharmaceuticals
• STADA
• Biocon
• Celltrion
• Dr. Reddy’s
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global biosimilar market snapshot
Exhibit 03: Key buying criteria for biosimilars 2015
Exhibit 04: Major timelines in global biosimilars market 2014-2020
Exhibit 05: Impact of key customer segments on market 2015
Exhibit 06: Definition of biosimilars in different regions
Exhibit 07: Comparison between biosimilars and generic small molecules
Exhibit 08: Factors affecting biologics and biosimilars market
Exhibit 09: Impact of biosimilars cost savings on various sectors
Exhibit 10: Factors affecting success of biosimilars
Exhibit 11: Biosimilars industry: Point-of-view
Exhibit 12: Factors influencing uptake of biosimilars
Exhibit 13: Global biosimilars market: Strategic factors for new market entrants
Exhibit 14: Challenges for new entrants
Exhibit 15: Bio-betters and its impact on market
Exhibit 16: Global biosimilars market: Pipeline snapshot 2015
Exhibit 17: Pipeline portfolio: Global biosimilars market 2015
Exhibit 18: Number of approved biosimilars in regulated and semi-regulated markets
Exhibit 19: Patent expirations of major biologics from 2000-2030
Exhibit 20: Global biosimilars market snapshot: Developed and emerging markets 2015
Exhibit 21: Patient assistance programs by vendors
Exhibit 22: Global biosimilars market 2015-2020 ($ billions)
Exhibit 23: Global spending for biosimilars 2015-2020 ($ billions)
Exhibit 24: Global biosimilars market: Key metrics analysis snapshot
Exhibit 25: Current and future trends in global biosimilars market
Exhibit 26: Impact of drivers and challenges on global biosimilars market
Exhibit 27: Five forces analysis
Exhibit 28: Global biosimilars market: Segmentation by application (2015-2020)
Exhibit 29: Applications of biosimilars and its impact on growth of market
Exhibit 30: Global biosimilars market: Segmentation by application 2015
Exhibit 31: Global biosimilars market segmentation: Growth cycle analysis
Exhibit 32: Global blood disorders market biosimilar 2015-2020 ($ billions)
Exhibit 33: Opportunity analysis of global blood disorders biosimilar market by type of application
Exhibit 34: Global oncology biosimilar market 2015-2020 ($ billions)
Exhibit 35: Opportunity analysis of global oncology biosimilar market by type of application
Exhibit 36: Population aged 60 years and over (millions)
Exhibit 37: Global chronic and autoimmune diseases biosimilars market 2015-2020 ($ millions)
Exhibit 38: Opportunity analysis of chronic and autoimmune diseases biosimilars market by application
Exhibit 39: Global growth hormone deficiency biosimilars market 2015-2020 ($ millions)
Exhibit 40: Opportunity analysis of global growth hormone deficiency biosimilars market
Exhibit 41: Global infectious diseases biosimilars market 2015-2020 ($ millions)
Exhibit 42: Opportunity analysis of infectious diseases biosimilars market by application
Exhibit 43: Global biosimilars market segmentation by application 2015
Exhibit 44: Biosimilars market segmentation by end-user 2015
Exhibit 45: Global biosimilars market: Geography outlook (2015-2020)
Exhibit 46: Global biosimilars market: Geography outlook 2015
Exhibit 47: Revenue/growth outlook in different countries/regions 2015
Exhibit 48: Biosimilar market landscape: Country analysis
Exhibit 49: Market penetration of originators and biosimilars in different regions
Exhibit 50: Biosimilars market in EMEA 2015-2020 ($ billions)
Exhibit 51: Biosimilars market in EMEA by region 2015
Exhibit 52: Guidelines for biosimilars in EU
Exhibit 53: Timeline of biosimilars in Europe
Exhibit 54: Geographical segmentation in Europe 2015
Exhibit 55: Patent expirations of major biologics in Europe
Exhibit 56: Key leading countries in EMEA 2015
Exhibit 57: Biosimilars market in Europe 2015-2020 ($ billions)
Exhibit 58: Europe biosimilars market: Opportunity analysis
Exhibit 59: Approved marketed products in Europe
Exhibit 60: Key stake holders in EU biosimilars market
Exhibit 61: PEST analysis: Biosimilars market in Europe 2015
Exhibit 62: Biosimilars market in Germany 2015-2020 ($ millions)
Exhibit 63: Biosimilars market in UK 2015-2020 ($ millions)
Exhibit 64: Biosimilars market in France 2015-2020 ($ millions)
Exhibit 65: Biosimilars market in Italy 2015-2020 ($ millions)
Exhibit 66: Biosimilars market in Spain 2015-2020 ($ millions)
Exhibit 67: Biosimilars market in APAC 2015-2020 ($ billions)
Exhibit 68: Biosimilars market in APAC by country 2015
Exhibit 69: Key leading countries in APAC 2015
Exhibit 70: Biosimilars market in China 2015-2020 ($ millions)
Exhibit 71: China biosimilars market: Opportunity analysis
Exhibit 72: PEST analysis: Biosimilars market in China
Exhibit 73: Timeline for development of biosimilars in India
Exhibit 74: Challenges and strategies in developing biosimilars in India
Exhibit 75: Biosimilars market in India 2015-2020 ($ millions)
Exhibit 76: India biosimilars market: Opportunity analysis
Exhibit 77: Approved biosimilars in India
Exhibit 78: PEST analysis: Biosimilars market in India 2015
Exhibit 79: Review process for biosimilars in Japan
Exhibit 80: Biosimilars approved by PMDA in Japan
Exhibit 81: Biosimilars market in Japan 2015-2020 ($ millions)
Exhibit 82: Biosimilars market in Japan: Opportunity analysis
Exhibit 83: PEST analysis: Biosimilars market in Japan 2015
Exhibit 84: Biosimilars market in Americas 2015-2020 ($ billions)
Exhibit 85: Approvals of biologicals versus biosimilars via public health service act (PHSA)
Exhibit 86: Timeline of biosimilar regulations in US
Exhibit 87: Approval process for biosimilars in US
Exhibit 88: Benefits of biosimilars to US healthcare system
Exhibit 89: Patent expirations of major biologics in US
Exhibit 90: Biosimilars market in US 2015-2020 ($ million)
Exhibit 91: Biosimilars market in US: Opportunity analysis
Exhibit 92: Role of stakeholders in creating awareness in US
Exhibit 93: PEST analysis: Biosimilars market in US 2015
Exhibit 94: Global biosimilars market: Key leading countries (2015)8
Exhibit 95: Patent analysis of biologicals in US
Exhibit 96: Patent analysis of biologicals in Europe
Exhibit 97: Impact of drivers
Exhibit 98: Key reasons as to why physicians are reluctant to prescribe biosimilar6
Exhibit 99: Impact of drivers and challenges
Exhibit 100: Global biosimilars market: Impact assessment of key trends
Exhibit 101: Competitive assessment of vendors
Exhibit 102: Key vendors: Geographical presence 2015
Exhibit 103: Mergers, acquisitions and partnership assessment of major vendors in global biosimilars market
Exhibit 104: Sandoz: YoY revenue and growth rate of biosimilars 2014-2015 ($ millions)
Exhibit 105: Sandoz: Metrics analysis
Exhibit 106: Hospira: Metrics analysis4
Exhibit 107: Teva Pharmaceuticals: Metrics analysis6
Exhibit 108: STADA: Metrics analysis
Exhibit 109: Biocon: Metrics analysis
Exhibit 110: Celltrion: Metrics analysis
Exhibit 111: Dr. Reddy’s: Metrics analysis
【レポート販売概要】
■ タイトル：バイオシミラー（バイオ後続品）の世界市場2016-2020■ 英文：Global Biosimilars Market 2016-2020
■ 発行日：2016年8月1日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10077
■ 調査対象地域：グローバル
- 高機能ファブリックの世界市場：コーティング布、ポリアミド、ポリエステル、複合ファブリック、アラミドThe performance fabric market is projected to reach 79.55 Billion by 2020, registering a CAGR of 4.8% between 2015 and 2020. Increasing awareness regarding personal hygiene and physical fitness and advancement in performance fabric production technology are the major drivers of the market. The performance fabrics market is witnessing high growth on account of increasing demand from industrial, def …
- Petroleo Brasileiro S.A.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Petroleo Brasileiro S.A. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Petroleo Brasileiro S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 世界の獣脂脂肪酸市場2015The Global Tallow Fatty Acids Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Tallow Fatty Acids industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Tallow Fatty Acids market analysis is provided for the international markets including development t …
- FPGAの世界市場予測（～2023年）：SRAM、アンチヒューズ、フラッシュThe FPGA market is expected to be valued at 5.83 Billion in 2017 and is projected to reach USD 9.50 Billion by 2023, at a CAGR of 8.5% between 2017 and 2023. The growth of this market is propelled by the growth of IoT and reduction in time-to-market. Telecommunications held the largest size of the FPGA market in 2016. This vertical contributes significantly to the economy of most of the countries …
- エチレンオキシド及びエチレングリコールの世界市場2016-2020About Ethylene Oxide and Ethylene Glycol Ethylene oxide is a chemically reactive material. It is used for manufacturing ethylene glycols, glycol ethers, ethanolamines, surface-active agents, and polyether polyols. Ethylene glycol is a clear, viscous, versatile organic compound that is a hydroscopic liquid at room temperature. It is used in the manufacture of polyester films, fibers and PET resins, …
- Oil & Gas Development Company Limited：石油・ガスの開発・生産動向及びコスト分析– 2012Oil & Gas Development Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Oil & Gas Development Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The r …
- 世界のセット トップ ボックス市場動向（2014-2018）TechNavio's analysts forecast the Global Set Top Box market to grow at a CAGR of 2.14 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increase adoption of HD STB. The Global Set Top Box market has also been witnessing the growth in the number of pay TV subscribers. However, the high cost of advanced set top boxes could pose a challenge to the gro …
- 調理済み食品のグローバル市場：新たな市場機会Summary “Identifying new opportunities in the Prepared Meals markets and responding to evolving consumer need states”provides detailed insight into new opportunities in Prepared Meals in both developing and developed countries. The evolution of consumption habits across the world means both retailers and manufacturers need a renewed understanding of consumer's changing lifestyles, and how this wil …
- 世界の内視鏡検査装置市場動向及び予測（～2018）Over the years, the endoscopy equipment market, which comprises endoscopes and visualization equipment, has witnessed various technological advancements. These advancements have led to a growth in the number of application areas of endoscopic equipment. Endoscopy devices are used in laparoscopy, arthroscopy, bronchoscopy, gastrointestinal endoscopy, urology, gynecology, and neuroendoscopy, among o …
- 産業用制御およびファクトリーオートメーションの世界市場予測（～2024年）“The industrial control and factory automation industrial control and factory automation market to exhibit significant growth from 2018 to 2024”The industrial control and factory automation market is expected to grow from USD 160.0 billion in 2018 to USD 269.5 billion by 2024, at a CAGR of 9.08%. The growth of this market can be attributed to the the increasing use of enabling technologies in manu …
- 政府地理空間情報（GEOINT）ソリューションの世界市場2016-2026GEOINT Solutions – our new study reveals trends, R&D progress, and predicted revenues Where is the GEOINT solutions market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our 492 page report provides 47 …
- アセチレンガスの世界市場2017-2021About Acetylene GasAcetylene gas is highly flammable with a characteristic property of high flame temperature. On combustion with oxygen, it can achieve a temperature of 6,296°F and on reaction with air can get to 4,532°F. It is a colorless gas with a garlic-like odor. Acetylene is an asphyxiant that reduces the amount of oxygen present in air. It is highly unstable in its pure form and tends to b …
- Greenfields Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Greenfields Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Greenfields Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The repor …
- 機能性炭水化物の世界市場：イソモルト、パラチノース、シクロデキストリン、カードランFunctional carbohydrates are non-cariogenic, low glycemic, and slow digestible carbohydrates, which are used in functional food and beverages as they promotes reduction in the blood level response. These functional carbohydrates play a vital role in enhancing immune system, reducing the risk of diabetes, and supporting energy and weight management. These functional carbohydrates are available in s …
- 世界の加工デンプン市場動向及び予測（～2018）The market for modified starch is expected to experience a growth of 4.1% from 2013 to 2018. The estimation is owed to the regular research & development in the industry with a wide application of modified starch in different industries. The modified starch industry has also brought global attention to the crops such as tapioca that has found in abundance in Southeast Asia. The mentioned reason is …
